{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:16:43Z","timestamp":1777699003658,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002583","name":"Gyeongsang National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002583","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Ministry of Trade, Industry and Energy","doi-asserted-by":"publisher","award":["NRF-2020R1C1C1015024"],"award-info":[{"award-number":["NRF-2020R1C1C1015024"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2020R1C1C1012379"],"award-info":[{"award-number":["NRF-2020R1C1C1012379"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.bmcl.2023.129528","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:08:41Z","timestamp":1697422121000},"page":"129528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synthesis and evaluation of 18F-labeled procainamide as a PET imaging agent for malignant melanoma"],"prefix":"10.1016","volume":"96","author":[{"given":"Ayoung","family":"Pyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misun","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boreum","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2832-896X","authenticated-orcid":false,"given":"Seong-Young","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Joon","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2023.129528_b0005","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3390\/diagnostics12051116","article-title":"Translating molecules into imaging-the development of new PET tracers for patients with melanoma","volume":"12","author":"Vercellino","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.bmcl.2023.129528_b0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejca.2016.01.011","article-title":"Treatment patterns of advanced malignant melanoma (stage III-IV) \u2013 A review of current standards in Europe","volume":"60","author":"Harries","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bmcl.2023.129528_b0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","article-title":"European Association of Dermato-Oncology, European Organisation for Research and Treatment of Cancer. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline \u2013 Update 2016","volume":"63","author":"Garbe","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bmcl.2023.129528_b0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454","article-title":"Malignant melanoma: skin cancer-diagnosis, prevention, and treatment","volume":"30","author":"Ahmed","year":"2020","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.bmcl.2023.129528_b0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2967\/jnumed.118.221416","article-title":"N-(2-(Dimethylamino)Ethyl)-4-18F-fluorobenzamide: A novel molecular probe for high-contrast PET imaging of malignant melanoma","volume":"60","author":"Pyo","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0030","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1021\/acs.jmedchem.8b01222","article-title":"Reducing the lipophilicity of perfluoroalkyl groups by CF2-F\/CF2-Me or CF3\/CH3 exchange","volume":"61","author":"Jeffries","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129528_b0035","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.2493080240","article-title":"Role of PET in the initial staging of cutaneous malignant melanoma: systematic review","volume":"249","author":"Krug","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.bmcl.2023.129528_b0040","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1371\/journal.pmed.0020070","article-title":"Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD","volume":"2","author":"Haubner","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0045","first-page":"1927","article-title":"3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma","volume":"44","author":"Cobben","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0050","first-page":"248","article-title":"Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and 15O-water using compartment and noncompartment analysis","volume":"42","author":"Dimitrakopoulou-Strauss","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0055","first-page":"1806","article-title":"Carbon-11-methionine PET imaging of malignant melanoma","volume":"36","author":"Lindholm","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.soc.2007.03.004","article-title":"Imaging studies in patients with melanoma","volume":"16","author":"Choi","year":"2007","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.bmcl.2023.129528_b0065","first-page":"957","article-title":"Role of nuclear medicine in the management of cutaneous malignant melanoma","volume":"47","author":"Belhocine","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0070","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7150\/thno.17117","article-title":"Preclinical melanoma imaging with 68Ga-labeled \u03b1-melanocyte-stimulating hormone derivatives using PET","volume":"7","author":"Zhang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.bmcl.2023.129528_b0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejps.2017.06.026","article-title":"Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific 68Ga- and 44Sc-labeled DOTA-NAPamide in melanoma imaging","volume":"106","author":"Nagy","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmcl.2023.129528_b0080","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00259-014-2791-x","article-title":"[18F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing \u03b1\u03bd\u03b2 3 and \u03b1\u03bd\u03b2 5 integrins","volume":"41","author":"Mena","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bmcl.2023.129528_b0085","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00259-008-0757-6","article-title":"68Ga- and 111In-labelled DOTA-RGD peptides for imaging of \u03b1\u03bd\u03b2 3 integrin expression","volume":"35","author":"Decristoforo","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.bmcl.2023.129528_b0090","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1158\/1078-0432.CCR-06-0266","article-title":"Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin \u03b1\u03bd\u03b23 expression in man","volume":"12","author":"Beer","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2023.129528_b0095","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1021\/jm501845n","article-title":"Synthesis and evaluation of 4-halogeno-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-[11C]methy lbenzamide for imaging of metabotropic glutamate 1 receptor in melanoma","volume":"58","author":"Fujinaga","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129528_b0100","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2967\/jnumed.112.105908","article-title":"In vivo measurement of the affinity and density of metabotropic glutamate receptor subtype 1 in rat brain using 18F-FITM in small-animal PET","volume":"53","author":"Yamasaki","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0105","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1021\/acs.inorgchem.6b00395","article-title":"New bifunctional chelator p-SCN-PhPr-NE3TA for copper-64: synthesis, peptidomimetic conjugation, radiolabeling, and evaluation for PET imaging","volume":"55","author":"Gai","year":"2016","journal-title":"Inorg Chem"},{"key":"10.1016\/j.bmcl.2023.129528_b0110","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2967\/jnumed.114.144881","article-title":"PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates","volume":"55","author":"Beaino","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0115","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11307-016-1024-z","article-title":"Improved radiosynthesis and biological evaluations of L- and D-1-[18F]fluoroethyl-tryptophan for PET imaging of IDO-mediated kynurenine pathway of tryptophan metabolism","volume":"19","author":"Xin","year":"2017","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.bmcl.2023.129528_b0120","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.7150\/thno.19371","article-title":"Synthesis of 5-[18F]fluoro-alpha-methyl tryptophan: new Trp based PET agents","volume":"7","author":"Giglio","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.bmcl.2023.129528_b0125","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2967\/jnumed.117.193268","article-title":"Imaging of programmed cell death ligand 1: Impact of protein concentration on distribution of anti-PD-L1 SPECT agents in an immunocompetent murine model of melanoma","volume":"58","author":"Nedrow","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0130","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1038\/s41598-017-02691-3","article-title":"Pilot study of 64Cu(I) for PET imaging of melanoma","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2023.129528_b0135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2967\/jnumed.113.133850","article-title":"Theranostics of malignant melanoma with 64CuCl2","volume":"55","author":"Qin","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0140","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1021\/jm301740k","article-title":"Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma","volume":"56","author":"Liu","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2023.129528_b0145","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1016\/j.bmc.2012.06.047","article-title":"Synthesis and characterization of a 68Ga-labeled N-(2-diethylaminoethyl)benzamide derivative as potential PET probe for malignant melanoma","volume":"20","author":"Kim","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2023.129528_b0150","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1016\/j.bmcl.2012.06.043","article-title":"Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging","volume":"22","author":"Kim","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2023.129528_b0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2967\/jnumed.109.070060","article-title":"High-contrast PET of melanoma using 18F-MEL050, a selective probe for melanin with predominantly renal clearance","volume":"51","author":"Denoyer","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0160","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2967\/jnumed.109.066175","article-title":"Melanin-targeted preclinical PET imaging of melanoma metastasis","volume":"50","author":"Ren","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0165","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1073\/pnas.1922313117","article-title":"Ultrasensitive detection of malignant melanoma using PET molecular imaging probes","volume":"117","author":"Pyo","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2023.129528_b0170","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7150\/jca.17550","article-title":"In vivo imaging of experimental melanoma tumors using the novel radiotracer 68Ga-NODAGA-Procainamide (PCA)","volume":"8","author":"Kertesz","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.bmcl.2023.129528_b0175","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1016\/j.bmcl.2016.06.022","article-title":"Preparation and characterization of a novel Al18F-NOTA-BZA conjugate for melanin-targeted imaging of malignant melanoma","volume":"26","author":"Chang","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2023.129528_b0180","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/912498","article-title":"Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma","volume":"2014","author":"Wu","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bmcl.2023.129528_b0185","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/bc8005094","article-title":"Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors","volume":"20","author":"Garg","year":"2009","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bmcl.2023.129528_b0190","first-page":"1573","article-title":"Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma","volume":"32","author":"Michelot","year":"1991","journal-title":"J Nucl Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpba.2017.02.049","article-title":"Comparative preclinical evaluation of 68Ga-NODAGA and 68Ga-HBED-CC conjugated procainamide in melanoma imaging","volume":"139","author":"Trencsenyi","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.bmcl.2023.129528_b0200","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Network","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2023.129528_b0205","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ejca.2012.11.004","article-title":"BRAF inhibitor activity in V600R metastatic melanoma","volume":"49","author":"Klein","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bmcl.2023.129528_b0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"METRIC Study Group. Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Flaherty","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0215","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0220","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2023.129528_b0225","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Eggermont","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2023.129528_b0230","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1245\/s10434-010-1111-3","article-title":"Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial","volume":"17","author":"Alkureishi","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.bmcl.2023.129528_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2019.09.007","article-title":"Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France","volume":"123","author":"Moya-Plana","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bmcl.2023.129528_b0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2017.05.014","article-title":"Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma","volume":"81","author":"Heppt","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bmcl.2023.129528_b0245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/cancers3010126","article-title":"Decoding melanoma metastasis","volume":"3","author":"Damsky","year":"2010","journal-title":"Cancers (Basel)"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23004067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X23004067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:49:54Z","timestamp":1760773794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X23004067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":49,"alternative-id":["S0960894X23004067"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129528","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of 18F-labeled procainamide as a PET imaging agent for malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2023.129528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129528"}}